KINGSTON, ON -- Groundbreaking research by KGHRI clinician scientist Dr. Stephen Archer was celebrated today with the opening of the William J. Henderson Laboratory, home of the Archer Laboratory Program on Cardiovascular Sciences and Mitochondrial Biology.
The laboratory, located in Botterell Hall, Queen’s University, was established thanks to a $500,000...Read more
An intensive care physician with the Kingston General Hospital Research Institute has been awarded $5.7 million to study the use of glutamine on patients with severe burns.
Dr. Daren Heyland is lead investigator in the five-year study, which will examine the effectiveness of glutamine, an inexpensive nutrient, on 2,700 patients...Read more
Researchers at Kingston General Hospital will soon have a dedicated space for their investigations and collaborations. Early design and development stages of the $5.7 million, 10,000 square-foot W.J. Henderson Centre for Patient-Oriented Research have been approved by the Ontario Ministry of Health and Long-Term Care. Construction tendering will begin in...Read more
A new mobile phone app has been launched in Kingston with a goal of saving the lives of people who experience cardiac arrest outside of the hospital. Kingston is the first community in Canada to introduce PulsePoint – a free app that is already saving lives in more than 1,000...Read more
Roger Deeley, President of the Kingston General Hospital Research Institute and Vice-Dean, Research, Queen’s Faculty of Health Sciences, has been named a Fellow of the Royal Society of Canada. Peer-selected fellowship in the Royal Society is one of the highest honours bestowed on Canadian scholars, artists and scientists in the...Read more
Trustees from the William James Henderson Foundation pledged $1 million over four years to the University Hospital Kingston Foundation (UHKF), their largest gift to date, to help build the Centre for Patient-Oriented Research at Kingston General Hospital (KGH). In recognition of this generous gift, the new research facility will be...Read more
A synthetic stool treatment tested at Kingston General Hospital has been getting quite a bit of national and international attention, and with good reason. The proof-of-concept trial has been shown to cure those experiencing chronic C. difficile infections.
The results of the trial were just published...Read more
A synthetic stool treatment transplanted during a proof-of-concept trial at Kingston General Hospital has been shown to cure those who experience chronic C. difficile infections.
The results of the trial were published in Microbiome, a peer-reviewed scientific journal and were part of a co-authored study written by...Read more